Purchase Order 75N98019P03002

<p>The Office of Logistics and Acquisition Operations awarded a purchase order to 10X Genomics, Inc. for chromium single-cell reagents to generate single-cell transcriptional profiles, valued at $22,103.00, on August 27, 2018. Place of performance is Pleasanton, California. The order carries firm fixed price terms and was due for completion by September 26, 2018.</p>

<p>The National Institutes of Health Office of Logistics and Acquisition Operations awarded a purchase order to 10X Genomics, Inc. on July 31, 2017 for Chromium Single Cell 3' Library &amp; Gel Bead Kit V2, 16 reactions, with a ceiling value of $40,097.00 under firm fixed price. Performance occurs at Bethesda, Maryland. The order was completed August 3, 2017.</p>

The Office of Logistics and Acquisition Operations awarded a purchase order to 10X Genomics, Inc. valued at $102,950.00 on December 11, 2020, with a final completion date of March 15, 2021. The order is firm fixed price with no set-aside designation. Performance takes place in Pleasanton, California. 10X Genomics supplies advanced genomic analysis platforms, reagents, instruments, and bioinformatics software, including single-cell and spatial transcriptomics technologies for biomedical...

<p>The National Human Genome Research Institute awarded a purchase order to 10X Genomics, Inc. for Chromium Next GEM Chip G Single Cell Kit (48 reactions) valued at $22,067.00, awarded December 4, 2020, with completion targeted for January 15, 2021. Performance occurs in Pleasanton, California. The order is firm fixed price with no set-aside designation.</p>

The U.S. government awarded a firm fixed-price purchase order valued at $9,808.00 to 10X Genomics, Inc. for one Chromium Genome Chip Kit V2 (48 reactions) on September 19, 2017. The contract, which was performed in Pleasanton, California, carried an ultimate completion date of October 18, 2017. No set-aside designation was applied to this procurement, and the funding was provided by a civilian federal agency within the Southeast Area. 10X Genomics, Inc., a biotechnology company specializing in...

<p>The NIH Office of Logistics and Acquisition Operations issued a BPA call to 10X Genomics, Inc. on April 28, 2026, with a ceiling value of $23,458.00 for Chromium Next GEM single cell multiome reagent bundles and Chromium Next GEM chip kits. Place of performance is Pleasanton, California. The call carries an ultimate completion date of April 27, 2027. Pricing is firm fixed price, and no set-aside was used.</p>

<p>The NIH Office of Logistics and Acquisition Operations awarded a purchase order to 10X Genomics, Inc. for a Chromium controller and accessory kit valued at $149,999 on July 2, 2018, with completion targeted for July 20, 2018. The order is a firm fixed price acquisition with no set-aside. Performance occurs in Bethesda, Maryland.</p>

The NIH Clinical Center awarded a purchase order to 10X Genomics, Inc. for Chromium Next GEM Single Cell V(D)J Kit v31.1 with Feature Barcode for Cell Surface Protein, valued at $25,919.00, on June 22, 2020. Work is performed in Pleasanton, California. The ultimate completion date was July 22, 2020. The order was issued under firm fixed-price pricing with no set-aside designation and originated from a pre-solicitation opportunity posted June 11, 2020 with a June 18 due date. The purchase order...

<p>The National Heart Lung and Blood Institute awarded a purchase order to 10X Genomics, Inc. for $22,366.00 on August 4, 2017, for Chromium single-cell library and gel bead kits, Chromium single-cell A chip kits, and Chromium I7 multiplex kits. The order carries firm fixed price, no set-aside designation. Place of performance is Pleasanton, California. Ultimate completion date is September 4, 2017.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to 10X Genomics, Inc. for Chromium Next GEM Single Cell 3' Kits on August 1, 2021, with a ceiling value of $328,092.12. Performance is located in Pleasanton, California. The order is firm fixed price with no set-aside designation. Ultimate completion was scheduled for July 31, 2023. The solicitation was posted on July 16, 2021 with a proposal due date of July 22, 2021.</p>